CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
66.23
-0.87 (-1.30%)
At close: May 6, 2025, 4:00 PM
66.00
-0.23 (-0.35%)
After-hours: May 6, 2025, 4:15 PM EDT
CVS Health Market Cap
CVS Health has a market cap or net worth of $83.78 billion as of May 6, 2025. Its market cap has decreased by -4.06% in one year.
Market Cap
83.78B
Enterprise Value
152.34B
1-Year Change
-4.06%
Ranking
Category
Stock Price
$66.23
Market Cap Chart
Since December 1, 1998, CVS Health's market cap has increased from $19.55B to $83.78B, an increase of 328.59%. That is a compound annual growth rate of 5.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 5, 2025 | 84.88B | 50.26% |
Dec 31, 2024 | 56.49B | -44.41% |
Dec 29, 2023 | 101.61B | -17.02% |
Dec 30, 2022 | 122.45B | -10.08% |
Dec 31, 2021 | 136.18B | 52.33% |
Dec 31, 2020 | 89.40B | -7.50% |
Dec 31, 2019 | 96.65B | 44.79% |
Dec 31, 2018 | 66.75B | -9.11% |
Dec 29, 2017 | 73.44B | -12.73% |
Dec 30, 2016 | 84.15B | -22.27% |
Dec 31, 2015 | 108.26B | -1.94% |
Dec 31, 2014 | 110.41B | 29.61% |
Dec 31, 2013 | 85.19B | 41.32% |
Dec 31, 2012 | 60.28B | 13.56% |
Dec 30, 2011 | 53.08B | 12.35% |
Dec 31, 2010 | 47.25B | 3.99% |
Dec 31, 2009 | 45.43B | 10.07% |
Dec 31, 2008 | 41.28B | -29.69% |
Dec 31, 2007 | 58.71B | 130.61% |
Dec 29, 2006 | 25.46B | 18.34% |
Dec 30, 2005 | 21.51B | 19.30% |
Dec 31, 2004 | 18.03B | 26.40% |
Dec 31, 2003 | 14.27B | 45.39% |
Dec 31, 2002 | 9.81B | -15.18% |
Dec 31, 2001 | 11.57B | -50.74% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 736.14B |
Johnson & Johnson | 371.98B |
UnitedHealth Group | 367.30B |
AbbVie | 346.24B |
Novo Nordisk | 309.41B |
Abbott Laboratories | 230.27B |
AstraZeneca | 221.69B |
Novartis AG | 221.37B |